These findings highlight the importance of reliable methods for MYC detection, such as fluorescent in situ hybridization (FISH) or immunohistochemistry, to differentiate cutaneous angiosarcomas from atypical vascular lesions, which are typically MYC-negative (53). This evidence concerns the gene MYC and angiosarcoma.